Glass Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
11,730
+45
+0.4% +$6.9K 0.69% 40
2025
Q4
$1.61M Sell
11,685
-930
-7% -$122K 0.66% 41
2025
Q3
$1.62M Buy
12,615
+305
+2% +$37.2K 0.72% 40
2025
Q2
$1.49M Hold
12,310
0.79% 40
2025
Q1
$1.37M Sell
12,310
-150
-1% -$16K 0.82% 41
2024
Q4
$1.21M Hold
12,460
0.66% 43
2024
Q3
$1.43M Hold
12,460
0.79% 42
2024
Q2
$1.33M Sell
12,460
-65
-0.5% -$6.53K 0.78% 43
2024
Q1
$1.21M Buy
+12,525
New +$1.28M 0.74% 42

Other funds holding NVS

Glass Wealth Management's NVS Position: Q1 2026 in Review

Glass Wealth Management increased its Novartis (NVS) stake by 0.39% in Q1 2026, buying an estimated $6.9K and bringing the position to 11,730 shares worth $1.79M. The position accounts for 0.69% of the portfolio, ranked #40.

Glass Wealth Management first reported a position in NVS in Q1 2024 and has held it in 9 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Glass Wealth Management held 11,730 shares of Novartis worth $1.79M as of Q1 2026.
  • Glass Wealth Management bought 45 Novartis shares in Q1 2026, an estimated $6.9K.
  • Novartis made up 0.69% of Glass Wealth Management's portfolio in Q1 2026, its #40 holding.
  • Glass Wealth Management first reported a position in Novartis in Q1 2024 and has held it in 9 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Glass Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.